Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.

Oncology reports - 1 Oct 2009

Boldrini Laura, Alì Greta, Gisfredi Silvia, Ursino Silvia, Baldini Editta, Melfi Franca, Lucchi Marco, Comin Camilla E, Maddau Cristina, Tibaldi Carmelo, Camacci Tiziano, Servadio Adele, Mussi Alfredo, Fontanini Gabriella

Abstract excerpt

Targeting the epidermal growth factor receptor has played a central role in advanced non-small cell lung cancer research, treatment, and patient outcomes over the last several years; however, a number of questions about this approach remain to be addressed. Through the Istituto Toscano Tumori and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Erlotinib Hydrochloride

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gefitinib

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to Quinazolines

Share to ras Proteins

Share to Smoking

Source

Identifiers

PMID: 19724844
DOI: 10.3892/or_00000488

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19724844-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.PMID 19724844Read ↗

Epidermal growth factor receptor mutations in 510 Finnish non--small-cell lung cancer patients.Semantic proximity Read ↗

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition.Semantic proximity Read ↗

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.Semantic proximity Read ↗

Specificities of lung adenocarcinoma in women who have never smoked.Semantic proximity Read ↗

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort studySemantic proximity Read ↗

Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.Semantic proximity Read ↗

Pharmacogenetics of EGFR in Lung Cancer: Perspectives and Clinical ApplicationsSemantic proximity Read ↗

Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.Semantic proximity Read ↗

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.Semantic proximity Read ↗

The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients.Semantic proximity Read ↗

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.Semantic proximity Read ↗

Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.